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New Triazoloquinoxaline Ligand and its Polymeric 1D Silver(I) complex 
Synthesis, Structure, and Antimicrobial activity 
Morsy A. M. Abu-Youssef[a*],  Saied M. Soliman[a],  Ayman El-Faham[a,b],  Jörg Albering[c],  
Mona M. Sharaf [d],  Yousry M. Gohar[e], Eliano Diana [f], Karl Gatterer[g] and Sidney F.A 
Kettle[h] 
Abstract 
The organic ligand 4-Benzyl-1-(N,N-dimethylamino)-[1,2,4]triazolo[4,3a]quinoxaline 1 (L) and its polymeric silver(I) 
complex, [Ag2L(NO3)2]n (2), have been synthesized and characterized. The organic ligand 1 crystallizes in the triclinic space 
group P¯1. The unit cell contains two parallel-stacked molecules. The complex [Ag2L(NO3)2]n (2) crystallizes in the 
monoclinic space group P21/n. The structure contains two different silver(I) ions. Ag(2) is coordinated by three oxygens 
(involving two nitrate groups) and to a nitrogen of the triazole ring of 1.  These ligands form a strongly distorted 
tetrahedral, nearly planar coordination sphere. Ag(1) has an approximately tetrahedral geometry.  It is bonded to one 
oxygen of a nitrate anion and a nitrogen of two different L; this aspect giving rise to an infinite chain structure.  A final 
bond to Ag(1) involves the carbon of a phenyl group.  It is more weakly bonded to the phenyl carbons on either side of 
this, so that the Ag(1)-phenyl bonding has aspects of an Ag-allyl bond. Ag(1) and Ag(2) participate in bonding to a common 
nitrate anion and alternate, the two distinct modes of bridging between them lead to a zig-zag chain structure.  In addition 
to spectroscopic studies, the biological activities of the ligand and of the complex were scanned over a wide range of Gram 
positive and Gram negative flesh- and bone-eating bacteria.  The results are discussed in comparison with well-known 
antibiotics. 
 
Introduction 
It is well recognised that the diffusion of increasingly drug resistant 
bacteria indicates a need for new antibiotics. The difficulty of 
designing new drugs can be overcame, as short-term measure, by 
modifying the characteristics of currently available antibiotics [1], 
by exploiting the fact that a lot of them can serve as metal ion 
ligands [2]. The bioavailability, membrane permeability [3] and 
distribution within the cell may thus be modified. Several groups 
have carried out work in this area; the present report concerns an 
apparently unique case which may be the precursor of a significant 
advance.  A triazole ligand (1) which forms a complex with the Ag(I) 
ion (2) and, apparently, no other ion, to give a complex stable in 
aqueous media is reported.  Closer investigation reveals that the 
complex contains Ag⋅⋅⋅π interactions with phenyl ring, and this 
presumably is the origin of its uniqueness.  The role of Ag-N and Ag-
O bonds in antimicrobial and antifungal activities have been 
explored [4], as well as the importance of Ag-C sigma bond [5], 
while the effect of Ag⋅⋅⋅π interaction in the same context has not yet 
been reported. We have checked the antibiotic activity of both the 
ligand 1 and the complex 2. Whilst both the Ag(I) ion and the ligand 
1 independently have antibacterial properties, in vitro the complex 
has a behavior that is more than the sum of its parts.   
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Triazoles are an important class of heterocyclic compounds.  In 
particular, fused 1,2,4-triazoles 3,4 (Scheme 1) may express 
antifungal,[6] bactericidal,[6,7] anxiolytic,[8,9] anticonvulsant [10] 
or herbicidal activities, [11] and can act as antidepressants[12]. 
Consequently, versatile and widely applicable methods for the 
synthesis of 3 and 4 are of considerable interest. Most methods are 
based on heterocyclic hydrazones or hydrazides as precursors.  
 
Scheme 1 
However, these methods have restricted applicability and use 
reagents such as lead tetraacetate, [13,14] bromine, [14,15] or 
phosphorus oxychloride[13] which it is better to avoid. Syntheses 
involving chloramine T [16], (diacetoxy)iodobenzene[17,18] or 
electrochemical methods [19] have also been introduced. Recently, 
[20,21] a low toxicity and inexpensive reagent, copper dichloride, 
has been used for the preparation of 1,2,4-triazole derivatives[20-
22] (Scheme 2).  
 
Scheme 2 
We recently reported a new method for the synthesis of 8 and 9 in 
a single step, which involves the reaction of 3-benzyl-2-
hydrazinoquinoxaline 6, or 1-hydrazinophthalazine hydrochloride 7 
with chlorouronium salts 5, to afford the 1,2,4-triazole derivatives 8 
and 9 in good yield and purity (Scheme 3) [23]. 
 Scheme 3 
In the present work we describe the synthesis of 4-Benzyl-1-(N, N-
dimethylamino)-[1, 2, 4]triazolo[4,3-a]quinoxaline (1) using 
Tetramethylfluoroformamidiniumhexafluorophosphate (TFFH, 10, 
Scheme 4)[24,25]. 1 reacts with silver nitrate to give the new 
complex (Ag2L(NO3)2)n 2, which has been appropriately 
characterized.   
NCH3
NCH3
CH3
CH3
F
CH3
CH3
N
N
N
N
N
PF
6
-
TFFH, 10
 
Scheme 4 
The ligand, L, 1, studied in this work 
 
We have made a detailed study of complexes of Ag(I) with several 
ligands [26], but the ligand 1 is particularly interesting because it 
does not seem to form complexes with common metal (we have 
not succeeded in preparing any complex in aqueous media, other 
than the complex with Ag(I)). Apart from the question of the 
specific interaction of 1 with the silver ion, there is a more 
important question about the role played by silver in bio-active 
systems. Since the antiquity, it has been known that metallic silver 
has an antibacterial action (although this aspect is 
controversial)[27]. At present, ceramic candles impregnated with 
colloidal silver are widely used in remote tropical areas to purify 
drinking water, and there is commercial production of broad-band 
silver additives which can be used for totally differing items, like 
food or clothing; in a completely different context, the silicone 
heart valve contains a silver-impregnated sewing ring, designed to 
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reduce the incidence of prosthetic valve endocarditis [28]. The 
presence of silver has been found to make antibiotics orders of 
magnitude more effective against gram-negative bacteria[29,30]. 
Studies in this area have shown an enhanced antibiotic activity of 
the silver complexes by respect both the free ligand (antibiotic) or 
the silver ion itself.  However, there is some uncertainty about the 
active species, attributable to two main problems. First, the 
biological environment may contain a variety of potentially 
complex-forming cations, that will be in competition with the silver 
ion for the antibiotic ligand. Second, unless there were a very large 
antibiotic enhancement it might be overlooked (the silver ion 
complex would normally be rather labile). Therefore, even if there 
were an enhancement due to the silver ion, the concentration of 
the silver complex present would be too low to be evident. With 
the lack of this evidence, possible small changes of the ligand that 
might enhance the relative stability of the silver complex have 
never been studied. Thirdly, the biological environment is often a 
reducing one, and it is possible that silver complexes may be 
reduced to metallic silver. This, of course, may have a bioactive 
effect, but usually this is attributed to the low concentration of Ag(I) 
ions arising from metallic silver. The present work is particularly 
relevant to the first of these problems. It seems that in aqueous 
media the ligand 1 forms water-stable complexes only with the 
silver ion. It is therefore possible to be confident that any observed 
enhancement of bioactivity results from the presence of the silver 
complex. 
Results and discussion 
Organic Ligand (1) 
The room temperature single crystal X-ray structure analysis of 
the organic ligand, 4-Benzyl-1-(N,N-dimethylamino)-
[1,2,4]triazolo[4,3a]quinoxaline, shows that it crystallizes in the 
triclinic system, space group P¯1 and contains dimeric π-π stacked 
species in the unit cell. The dimeric unit is shown in Figure 1 and 
the collection data detailed in Table 2.  The mechanism of 
dimerization is indicated in Figures 2 and 3. Figure 2 shows the 
packing of the dimeric units whilst the detail of Figure 3 indicates 
that the mechanism of dimerization is due to weak Van der Waals-
bonding between the H atoms of dimethylamino groups and the π 
electron system of phenyl rings. 
 
 
Figure 1   Labeling scheme and ellipsoids (30 % probability level) of 
the two ligand (1) molecules A and B in the asymmetric unit. The 
hydrogen atoms are not labeled for clarity in this plot. 
 
Figure 2    Packing scheme of the dimeric units of ligand (1) (view 
along [100]). The dimeric units are held together by π-stacking 
interactions. 
 
Figure 3   Contacts between some hydrogen atoms of the 
dimethylamino groups as well as protons bonded to an aromatic 
ring system with the π-electron system of the phenyl rings of 
neighboring molecules form van der Waals bonds in the structure 
of (1). The distances between the hydrogen atoms and the 
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centroids (red balls) of the phenyl rings range between 2.707 Å (H7 
– centroid) and 3.061 (H11B –centroid). 
 
[Ag2L(NO3)2]n (2)  
A room temperature single crystal X-ray structure 
determination established that the complex [Ag2L(NO3)2]n (2) 
crystallizes in the monoclinic system, space group P21/n (Figure 4 
shows the content of the asymmetric unit). The structure contains 
two different silver(I) ions (Figure 4). Ag(2) is in a strongly distorted  
tetrahedral, nearly planar, environment, coordinated to three 
oxygen atoms of two nitrate groups and to one nitrogen atom of 
the triazole ring of the ligand. The silver-nitrogen bond and two of 
the silver-oxygen bonds are in a range often found in silver nitrate 
complexes with nitrogen-containing ligands (Ag(2)-N(1): 2.239 Ǻ, 
Ag(2)-O(4): 2.338 Ǻ, Ag(2)-O(1): 2.389 Ǻ). These three ligand atoms 
form a triangular coordination around Ag(2). The fourth silver-
oxygen bond much weaker than the two other ones, indicated by a 
significantly longer (Ag(2)-O5): 2.610 Ǻ) distance. In addition to 
these four real bonds there are two further contacts with one 
oxygen (Ag(2)-O(2A): 2.82 Ǻ) and one carbon atom (Ag(2)-C(16): 
3.085 Ǻ) significantly shorter than the sum of the van der Waals 
radii of silver and oxygen (3.24 Ǻ), or silver and carbon (3.42 Ǻ).  
Ag(1) has a much less distorted tetrahedral geometry. A nitrate 
oxygen links it to Ag(2) and it is also bonded to a nitrogen of two 
different ligand molecules thus forming a zig-zag 1D chain (Figure 
5).  However, particularly interesting is the observation that Ag(1) 
bonds to the carbon of a phenyl group (Figure 6).  This is a long, but 
surely real, bond  (Ag(2)-C(13)): 2.72 Ǻ in comparison with 2.25 and 
2.34 Ǻ to nitrogens and 2.39 Ǻ to oxygen. Similar Ag-C bonds are 
normally ca 2.5 Ǻ.[31-34], but this is when there is no other 
bonding to Ag.  The Ag-C distances to the carbon atoms C(14) and 
C(18) neighbouring C(13) in the phenyl ring show also weak 
interactions with Ag(1) (Ag(1)-C(14): 2.897 Ǻ and Ag(1)-C(18): 3.002 
Ǻ); compared with the sum of Van der Waals radii of Ag and C of 
3.42 Ǻ, these contacts have to be considered as weakly bonding. 
Figure 4 illustrates the bonding situation described above. Some 
significant interaction involving these carbons is indicated, in which 
case the Ag-phenyl bonding is mediated through something akin to 
an allyl group (and Ag(1) six coordinate).   
The fourfold coordinations of the silver atoms have been 
analyzed by calculating the τ4 [31] and the τ4‘ [32] geometry index.  
 
τ4 =  (360°- (α + β)) / (360° - 2 θ)  
 
τ4‘ = (β – α) / 360°- θ) + (180° – β) / (180° – θ)    
 
with α, β and β > α: largest occuring bond angles in the fourfold 
coordination sphere and θ = ideal tetrahedral angle, 109.5°. The 
values for ideal square planar and tetrahedral coordination spheres 
are 0 and 1, respectively. 
 
The calculated geometry indices for the Ag(1) atom are τ4 ≈ 
0.695 and a τ4‘ ≈ 0.646, the respective values for Ag(2) are τ4 ≈ 
0.454 and a τ4‘ ≈ 0.371. It can be seen clearly that Ag(2) is closer to 
a distorted square planar arrangement, while the ligands around 
Ag(1) tend to form a distorted tetrahedron around the central 
atom. 
As mentioned above the Ag2L(NO3)2 units form 1D infinite zig-
zag chains in the structure. The structure shows a relatively dense 
packing, which is due to the numerous polar interactions between 
the nitrates and protons of the ligand molecules of neighbouring 
chains. A section of the coordination polymer and the projection of 
the crystal structures along [001] is shown in Figure 5. Both views 
emphasize the folded, fishbone-type packing of the 1D infinite 
coordination polymers.
 
Figure 4   Labeling scheme and ellipsoids (30 % probability level) in 
the complex unit of the silver compound (2). The hydrogen atoms 
are not labeled in this plot.  
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Figure 5  Upper part: The Ag2L(NO3)2 units form a one-dimensional 
infinite coordination polymer connected via Ag(1)-N(2) and Ag(1)-
N(4) bonds and a N(1)-Ag(2)-O(1)-Ag(1) bridge. This figure shows 
only a section of this coordination polymer containing five Ag(1) 
nodes and four ligand molecules. 
 
Lower part: Packing scheme of the complex (2), viewed along the c-
axis. The coordination polymers extend along the monoclinic b-axis 
of the crystal structure of the silver complex. The Ag-C interactions 
have been omitted for these figures. 
 
  
Figure 6   Coordination spheres of the two silver atoms. Some 
silver-carbon distances are significantly shorter than the sum of 
their v.d.W. radii of 3.42 Å: Ag1 – C13: 2.717(8) Å, Ag1 – C14: 
2.897(9) Å, Ag1 – C18: 3.002(9) Å, Ag2 – C16: 3.085(9) Å. The silver-
oxygen distances Ag2 – O5 (2.610(7) Å) and Ag2 – O2A (2.82(2) Å) 
are rather long compared with the other Ag – O bonds and should 
better be termed ‚contacts‘ rather than bonds. For this drawing the 
coordinating atoms have been emphasized, all other atoms are 
shown as semi-transparent ellipsoids. 
 
Another interesting aspect of the crystal structure of (2) is that 
it is accompanied by only a small distortion of the ligand. The 
heterocyclic backbone of this molecule is rigid; only the rotation 
around the sigma bond axes of the benzyl and the dimethylamino 
group, respectively, to the heterocyclic ring system allows some 
adaption to the requirements for a successful formation of 
complexes with metal atoms. Figure 7 illustrates the conformation 
of (1) in the crystal structures of the pure ligand and of the silver 
complex. It shows clearly that the major differences between the 
three molecules are mainly due to the rotation of the benzyl group. 
 
 
Figure 7   Comparison of the ligand conformations of the molecules 
A and B in the pure ligand structure (1) and in the Ag complex (2). 
 
A key question is why Ag(I) should behave differently from the 
other ions tested [Mn2+, Co2+, Ni2+, Cu2+, Cd2+, Zn2+]. There are two 
reasons that could serve as explanation. In silver complex (2) the 
ligand geometry is almost the same as in (1); this indicates that 
little distortion energy is required. Such a matching of geometric 
demands is rare and probably is unlikely to be found with 
alternative cations.  
Perhaps more important is the observation that Ag(I) contains a 
bond to at least one carbon of the ligand phenyl group. Whilst 
Ag(I)-aryl bonds are well known and have been characterized 
crystallographically (Ag(I)-C6H6 is perhaps the best known example), 
they are usually formed without supporting bonding from other 
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ligands. In the present case, however, Ag(I) is also bonded to two 
nitrogens (of different ligands) and these presumably play a role in 
enabling silver-carbon bonding. Not that Ag-C bonding alone is 
insignificant; binding energies of above 150 kJ mol-1 have been 
reported for Ag(I)-benzene species [35,36]. Meanwhile, nitrogen 
containing ligands have been reported to selectively coordinate Ag+ 
ions, also from water solution, because the ability of silver to 
establish Ag+-π interactions[37]. The best evidence comes from 
molecules in which more than one aromatic ring is involved, where 
geometrical changes consequent upon Ag(I) bonding are evident 
[37]. It should be noted that although the bonding of the Ag(I) in 
the present species conforms to the general geometric pattern 
[38], its participation in extended bonding seems unusual. This 
interaction sets Ag apart from all of the other cations that we have 
studied and which failed to form complexes with 1. Whether it is 
responsible for the enhancement of biological activities observed is 
impossible to say, although this possibility suggests a direction for 
future enquiry. Another contribution to the enhanced biological 
activity of the silver species is that the complex formed contains 
two silver ions, not one. These two ions are not independent but 
are linked, not only through the ligand, where they are bonded to 
adjacent nitrogens, but also through the oxygen of a nitrate group. 
As we have noted, Ag(1) is linked to a nitrogen of a separate ligand. 
This is the feature which leads to a polymeric structure in the solid 
but neither it nor the nitrate bridges can be expected to persist in 
aqueous solution. Clearly, the relationship between solid and 
solution structures of the complex becomes relevant. Here, the 
available relevant evidence comes from the NMR data, which 
indicate the persistence of either the complex or an immediately 
derived species in solution. In that, the complex contains two 
chemically different Ag(I) ions, and it cannot be assumed that they 
behave in the same way in the transition from solid to solution. So, 
it is possible that one Ag, probably Ag(1), remains complexed whilst 
the other is free in solution. Even so, the species present in the 
dilute aqueous solutions used in the actual measurements may 
differ from those in the NMR measurements and here the most 
relevant data perhaps comes from the biological measurements 
themselves, which indicate that the complex persists. 
 
Antimicrobial activity  
 The Minimum Inhibition Concentrations (MIC) of 1 and 2 were 
determined and compared with 17 antibiotics used for treatment of 
the infections reported in the experimental part; the obtained data 
are reported in Table 1. The last three rows of Table 1 demonstrate 
an independent behaviour  of Ag(I) and compounds 1 and 2. The 
complex under investigation, 2, shows potent activity when 
compared with the activity of other known antibiotics. In one case 
(bold) it is the most powerful. This finding is in general accord with 
previous results: Nomiya et al[39] reported good activities for 
[Ag(imidazole)2](NO3), [Ag(1,2,4-triazole)]n and [Ag(tetrazole)]n 
against both S. aureus and Ps. aeruginosa (MIC 15.7, 7.9, 15.7 and 
7.9, 7.9, 15.7 µg/ml) when compared to AgNO3 (MIC 62.5 µg/ml for 
both bacteria). [Ag(imidazole)]n and {[Ag(L-histidine)]2}n were 
equally active against Ps. aeruginosa and S. aureus(MIC 12.5 and 
15.7 µg/ml), while [Ag(1,2,3-triazole)]n showed no activity against 
these bacteria[40]. 
Zhang and co-workers investigated [Ag((8-pyridin-3-
yl)methylthio)quinoline]+ with different counter ions, and higher 
activities were recorded for CF3CO2
- against S. aureus and Ps. 
aeruginosa compared to NO3
- and CF3SO3
- (MIC 0.25 and 0.06 
µg/ml)[41].  This work suggests that the complexes function as ion 
pairs and that these differ, for instance, in their ability to penetrate 
the cell wall barrier. 
Our research group recently reported on the antimicrobial activities 
of Ag(I) nicotinate compounds [42] where [Ag2-µ-O,O’(2-
aminonicotinium)2-(NO3)2]n and [Ag(isonicotinamide)2-µ-
O,O’(NO3)]2 showed considerable activity against Ps. aeruginosa 
(MIC values 2-8 µg/mL), [Ag(ethyl nicotinate)2](NO3) against S. 
aureus (MIC 4-16 µg/mL) and S. pyogenes (MIC 2-4 µg/mL). 
[Ag(ethylnicotinate)2](NO3), [Ag(methylisonicotinate)2(H2O)](NO3) 
and [Ag(ethylisonicotinate)2(NO3)] showed remarkable activities 
against P. mirabilis (MIC 1-16 µg/mL). With the ligand 4,5-
diazafluoren-9-one we found considerable activity against S. 
aureus,  K. pneumoniae and P. mirabilis (MIC = 6, 4, and 4 µg/ml, 
respectively). 
The question to be addressed is whether there is evidence that 
the behaviour of the complex differs from that expected from the 
additive effects of Ag(I) and the ligand (that is, the `complete 
dissociation´ limit). The problem is complicated by the preliminary 
nature of the measurements, standard deviations are not available 
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(the work involved in obtaining them is great and difficult to 
justify). Assuming that the presence of the bacteria or some 
extracellular enzyme and/or the bacterial by-product do not 
influence equilibria (i.e. that one component is not selectively 
extracted), the answer seems clear; the complex retains its identity.  
Ag(I),  the ligand and the complex all exert significant anti-bacterial 
properties. With two exceptions, the complex either equals or out-
performs the other two.  The first exception is S. enterica, where 
Ag(I) is better than the complex by one, and perhaps two, orders of 
magnitude.  Clearly, the complex is not acting solely as a source of 
Ag(I); if it were, an exception of this magnitude would not exist.  It 
might also suggest that both the Ag(I) ions of the solid state 
compound remain coordinated in solution.  The other exception is 
M. luteus, where the complex is the least effective of the three, by 
an amount that seems greater than any likely standard deviation. In 
one case, from the raw data, the complex seems the most effective 
inhibitor tested. Taken together, these data  indicate that the 
complex retains its identity and is an effective anti-bacterial. To us 
this seems a significant conclusion.  The addition of substituents to 
the ligand, with the possibility of enhancing the inhibitory effect, is 
clearly an attractive forward step.  
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Table 1. Minimum inhibitory concentration (MIC) for 1 and 2 against multi drug-resistant diabetic foot bacteria (those in the Table not 
given ATCC numbers) compared with a number of commercial antibiotics.  
 
 Gram-positive bacteria Gram-negative bacteria 
Antibiotic 
M
. 
lu
te
u
s 
S
. 
a
u
re
u
s 
A
T
C
C
 6
5
3
8
p
 
S
. 
a
u
re
u
s 
E
. 
co
li
 
A
T
C
C
 8
7
3
9
 
E
. 
co
li
 
K
. 
p
n
e
u
m
o
n
ia
 
P
s.
 a
e
ru
g
in
o
sa
 
A
T
C
C
 9
0
2
7
 
P
s.
 a
e
ru
g
in
o
sa
 
S
. 
e
n
te
ri
ca
 
 MIC (µg/ml) 
Amikacin 8 4 32 8 32 >256 4 12 >256 
Gentamicin 16 16 16 4 16 32 12 24 64 
Streptomycin 64 12 64 6 32 64 8 16 32 
Amoxicillin 24 8 16 32 192 >256 8 256 >256 
Ampicillin 16 4 12 24 64 >256 4 12 >256 
Cephradine
i 64 16 12 24 128 192 16 128 8 
Cefuroxime
ii 32 8 24 16 64 128 8 64 12 
Cefoperazone
iii 16 6 16 12 24 96 32 12 24 
Cefepime
iv 8 4 8 4 32 64 8 32 12 
Imipenem 32 2 16 3 16 >256 8 >256 32 
Meropenem 16 2 12 2 64 192 4 128 16 
Azithromycin 16 12 24 12 32 64 12 128 96 
Clarithromycin 24 16 32 8 24 32 8 96 48 
Nalidixicacid
i 32 24 64 4 16 128 8 64 32 
Ciprofloxacin
ii 24 4 48 6 32 32 4 48 32 
Levofloxacin
iii 16 3 32 8 24 16 2 32 128 
Vancomycin 24 32 16 4 32 128 32 64 >256 
(Ag(l))* 12 24 12 24 32 16 64 48 12 
1 4 48 128 96 >256 128 24 32 >256 
2 32 12 12 24 32 8 12 16 >256 
 
 
Roman superscript numbers indicate the generation of the antibiotic. 
* Ag(l) ions are known to be toxic and with a very short half-life in body fluids.  They are also partially precipitated during the course of the 
bioassay. 
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Experimental 
 Material and instrumentation 
Silver nitrate was purchased from Aldrich Company. All other 
chemicals were of analytical grade quality and were used as 
received. Elemental analyses for C, H and N were carried out using 
a Perkin-Elmer analyser; Ag(I) was determined with a Perkin Elmer 
Analyst 300 AAS atomic absorption spectrometer. Infrared spectra 
(IR) were recorded as KBr pellets on a Shimadzu 8300 series Fourier 
Transformer. NMR spectra were recorded on a Jeol 500 MHz 
spectrometer at ambient temperature (25°C). Melting points were 
obtained in open capillary tubes using a Gallenkamp Sanyo melting 
point apparatus and were uncorrected.  
Abbreviation used in the text: TFFH = 1,1,3,3-
tetramethylfluoroformamidinium hexafluorophosphate; DMF = 
dimethylformamide; Et3N = triethylamine. 
 Synthesis 
Ligand 1, 4-Benzyl-1-(N,N-dimethylamino)-[1,2,4]triazolo 
[4,3a]quinoxaline. 
In the synthesis of this ligand, TFFH 10 (5 mmoles, 1.32 g) was 
added to a solution of 3-benzyl-2-hydrazinoquinoxaline 5 (5 
mmoles, 1.25 g) and triethylamine (10 mmoles, 1.32 ml) in DMF (10 
ml) and the reaction mixture was stirred at room temperature 
overnight. The reaction mixture was then poured into cold water. 
The solid formed was immediately filtered off and washed, first 
with water, then with saturated aqueous NaCl (30 ml) and then 
dried in a desiccator. The crude product was recrystallized from 
ethanol. The product was obtained as an orange solid in 64% yield 
(0.95 g), m.p. 166-167 ºC.  
Analytical data (%):Calc.: C, 71.26; H, 5.65; N, 23.09 Found: C, 
71.34; H, 5.57 ; N, 23.14. IR (KBr): 3100-2900 (C-H), 1620 (C=N), 
1540-1500 (C=C aromatic), 1480 (-CH2-), 1300 (C-N) cm
-1. 1H NMR 
(DMSO-d6): δ  2.93 (s, 6 H, 2 CH3), 4.48 (s, 2 H, 1 CH2), 7.20-7.27 (t t, 
1 H, aromatic), 7.29-7.32 (m, 2 H, aromatic), 7.45-7.48 (d d, 2 H, 
aromatic), 7.59-7.64 (t d, 1 H, aromatic), 7.67-7.73 (t d, 1 H, 
aromatic), 7.96-7.99 (d d, 1 H, aromatic), 8.41-8.45 (d d, 1 H, 
aromatic) ppm. ms: m/z 303 (M+): 304.2  
Synthesis of [Ag2L(NO3)2]n (2) 
To an aqueous solution, 10 ml, of silver nitrate (0.1 g, 0.59 mmol) a 
15 ml ethanolic solution of the organic ligand (C18H17N5), (0.3 g, 
~1.0 mmol) was added dropwise with constant stirring over about 
15 minutes. To the turbid solution, 2-3 drops of 0.1 M nitric acid 
solution were added with continuous stirring. The solution became 
clear and was repeatedly filtered until no more precipitate was 
noticed. The solution was allowed to stand for 3 weeks. Uniform, 
colourless to yellowish crystals suitable for X-ray measurements 
were collected and air dried. There was a yield of 0.075 g., about 
40% with respect to the metal. Whilst the infrared spectra show 
little sign of complex formation, the same is not true for the NMR. 
Calc.: C, 33.62; H, 2.66; N, 15.25; Ag, 33.56 Found: C, 33.57; H, 
2.60; N, 15.37; Ag, 33.65. IR (KBr): 3100-2910 (C-H), 1625 (C=N), 
1540-1500 (C=C aromatic), 1480 (-CH2-), 1310 (C-N) cm
-1. 1H NMR 
(DMSO-d6): δ  3.03 (s, 6 H, 2 CH3), 4.59 (s, 2 H, 1 CH2), 7.21-7.27 (d, 
1 H, aromatic), 7.29-7.55 (m, 2 H, aromatic), 7.56-7.88 (d, 2 H, 
aromatic), 7.59-7.64 (t, 1 H, aromatic), 7.64-7.73 (t, 1 H, aromatic), 
8.07 (d, 1 H, aromatic), 8.54 (d, 1 H, aromatic) ppm.   
The differences in chemical shifts between ligand and complex 
are to be noted; these differences are important because they 
permit the composition of solutions to be determined (the shifts 
are not concentration-dependent). 
Although the silver complex is the only one we have 
successfully prepared, we have explored the coordination of 1 with 
a variety of transition and other metals. An ethanolic solution of 
the ligand was added to aqueous solutions of several, 
representative, simple metal salts MCl2 and M(NO3)2 [M =  Mn, Co, 
Ni, Cu, Cd, Zn] by changing both temperature and reaction 
stoichiometry. In all cases, the only product was an essentially 
quantitative recovery of the organic ligand 
X-ray crystallography 
X-ray crystallographic data were collected on an Enraf-Nonius 590 
Kappa CCD single crystal diffractometer with graphite 
monochromator using MoKα (λ = 0.71073Å).   The intensities were 
collected at room temperature using a φ-ω scan mode; the crystal 
to detector distance was 40 mm. Further details are given in Table 
2. The cell refinement and data reduction were carried using Denzo 
and Scalepak’s programs[43]. Multiscan absorption corrections 
were applied to all data sets using the program SORTAV[44]. The 
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crystal structures were solved by direct methods, which revealed 
the positions of all non-hydrogen atoms, and subsequently refined 
by full matrix least square cycles based on F2, both using the SHELX 
package[45]. The temperature factors of all non-hydrogen atoms 
were refined anisotropically, before hydrogen atoms were 
introduced in a riding model with C-H = 0.96Å and refined 
isotropically. The data collection up to 50° in 2theta has been 
skipped by the operator of the diffractometer since there have 
been only a very small number of significant reflections in the 
range between 45-50 °; probably due to the room temperature 
measurement. Low temperature data collection were temporarily 
not available for these measurements.The Molecular graphics were 
prepared using the Diamond 3.0 program [46]. Crystallographic and 
refinement data are summarized in Table S1. Tables S2 and S3 list 
selected bond distances and angles for compounds 1 and 2, 
respectively.   
Biological measurements. 
Determination of Minimum Inhibitory Concentration (MIC). 
Antimicrobial activities of the organic ligand 1 and complex 2 were 
determined according to the recommendations of the National 
Committee for Clinical Laboratory Standard (NCCLS) 1999, by the 
use of the broth microdilution method. Bacteria used in this 
investigation were of two categories; standard bacteria from the 
American Type Culture Collection (ATCC) and clinical bacteria, all 
multi-drug resistant, isolated from diabetic foot ulcers by swabbing 
techniques. Minimum inhibitory concentrations (MICs) for the 
tested compound were measured using 9 different bacterial 
strains, three standard American Type Culture Collection (ATCC, 
namely: Staphylococcus aureus ATCC 6538p,  Escherichia coli ATCC 
8739 and Pseudomonas aeruginosa ATCC 9027 and 6 multidrug 
resistant (MDR) clinical virulent bacteria (isolated from diabetic 
foot ulcers), two Gram-positive; Micrococcus luteus, Staphylococcus 
aureus and four Gram negative,  Escherichia coli; Klebsiella 
pneumoniae; Pseudomonas aeruginosa and Salmonella enterica. All 
clinical bacteria were resistant to at least 10 commonly used 
antibiotics of choice for diabetic foot ulcers.  
The test materials were dissolved in DMSO to give a stock solution 
which was subsequently diluted in the growth medium to give final 
concentrations of 256, 128, 64, 32, 16, 8, 2, 1, and 0.5µg/ml. A final 
concentration of 5% DMSO was present in all assays, a 
concentration which had no antibacterial effect on its own (a 
control treatment, with all the tested bacteria using 10% DMSO 
showed no antimicrobial activity). Bacteria were cultured in 
Mueller Hinton broth (MHB) for 24 h at 35°C. The MIC value was 
that corresponding to the lowest concentration that inhibited 
bacterial growth. A toxicity bioassay against Daphnia magna was 
conducted using standard methods (US-EPA, 1999). 
Conclusions 
There have been many studies on the biological activity of 
metal-ligand combinations. So, the question of whether it is 
possible to enhance or make more selective the action of an 
antibiotic by complex formation has been much studied. A 
besetting problem is the question if trace concentrations of other 
metal species could distort the experimental data by competing 
with the chosen metal in complexing with the ligand. The system 
explored in the present work, with his specificity for Ag(I), is a rare 
case in which such complexities are absent. The complex studied 
shows a clear activity against a wide range of bacterial species. 
Since chemical modification of the ligand is a real possibility, it 
would be both possible and valuable to extend the present 
investigation. 
The structural analysis underlined the importance of the  Ag+-π 
bonds in the complex formation, and it will be of importance to 
check for the existence of this bonding in all related species that 
may be prepared. The structure of the complex 2 and the solution 
data suggest that the silver ion may be capable of a succession of 
weak bonding interactions along a molecular framework which 
enable it to gain a unique access to cellular structure and which 
lead to eventual cell death. That is, the Ag+-π and dispersion 
interactions involving the silver ion in biological systems could 
prove to be of real importance. 
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